Clinical trial
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
- Lead sponsor
- Peking University First Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- December 31, 2028
- Enrollment
- 2,522 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
liver cirrhosis, portal vein thrombosis